Skip to main content
. 2019 Feb 14;24(4):673. doi: 10.3390/molecules24040673

Figure 1.

Figure 1

Theaflavin-3,3′-digallate (TF3) selectively reduced the viability of ovarian cancer cells. (A) Chemical structure of TF3. (B) The viability of human ovarian carcinoma (OVCAR-3) cells and normal human immortalized ovarian surface epithelial cells (IOSE 364) cells exposed to TF3. * p < 0.05 compared with the control group.